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Abstract: The present study evaluated the effect of aflatoxin B1 (AFB1) and fumonisin B1 
(FB1) either alone, or in association, on rat primary hepatocyte cultures. Cell viability was 
assessed by flow cytometry after propidium iodine intercalation. DNA fragmentation and 
apoptosis were assessed by agarose gel electrophoresis and acridine orange and ethidium 
bromide staining. At the concentrations of AFB1 and FB1 used, the toxins did not decrease 
cell viability, but did induce apoptosis in a concentration and time-dependent manner.  
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1. Introduction  
Aflatoxins  are  biologically  active  metabolites  produced  by  the Aspergillus strains A.  flavus, A. 
parasiticus, A. nomius, and A. pseudotamarii [1]. The biological response to aflatoxin B1 (AFB1) in 
terms of genotoxicity and cytotoxicity depends on the metabolic formation of AFB1-8,9-epoxide [2], 
which can covalently bind to nucleic acids or proteins, provoking cell membrane damage, necrosis and 
mutagenesis in the affected cells [3]. 
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Fumonisins  are  secondary  metabolites  produced  mainly  by  Fusarium  verticillioides  and  
F. proliferatum [4,5]. Their mechanism of action is still not completely understood; however, these 
toxins show an extraordinary structural similarity to sphingoid bases, sphinganine and sphingosine, 
and as such selectively inhibit ceramide synthetase, a key enzyme in the biosynthetic pathway of 
sphingolipids  [6],  which  leads  to  an  increase  in  the  levels  of  sphinganine  and  occasionally  to 
sphingosine in the cell [7]. 
Apoptosis is a specialized process of cell death that is part of the normal development of organs and 
tissue maintenance, but may also occur as a response to various environmental stimuli, indicating 
toxicity. Since apoptosis can play a critical role in the development of cancer, the ability of toxins to 
induce apoptosis appears to be related to their toxicological effects [8]. 
One of the initial events that occurs in the target organs exposed to fumonisin is apoptosis, which 
might  be  a  consequence  of  the  inhibition  of  ceramide  synthetase  and  alterations  in  sphingolipid 
metabolism [9]. Another mechanism of apoptosis induction probably involves the inhibition of protein 
kinase  C  [10],  a  key  hallmark  of  apoptosis  signaling  [11]  and  destructuring  of  the  endothelial  
barrier [12]. 
The regulation of sphingolipid biosynthesis is essential for the cell, since its products affect the 
cellular behavior; ceramide and sphingosine are cytotoxic, inhibit growth and are able to induce early 
apoptosis. Sphingosine can be phosphorylated by sphingosine kinase to form sphingosine-1-phosphate, 
a  potent  mitogen  that  antagonizes  the  apoptotic  effect  mediated  by  ceramide.  A  model  has  been 
proposed  in  which  the  balance  between  the  intracellular  levels  of  ceramide  and  sphingosine-1-
phosphate could determine whether a cell survives or dies [13]. 
The co-occurrence of fumonisin B1 (FB1) and AFB1 has been reported by several researchers as a 
worldwide problem [14]. Although the clinical, biochemical, hematological and mycotoxicological 
parameters of both toxins acting alone have been well studied [15], at present, little is known about the 
interaction  of  AFB1  and FB1 regarding their toxic and carcinogenic properties and the interactive 
effects of these toxins in vivo. 
The present study describes the isolated and combined effects of AFB1 and FB1 on rat primary 
hepatocyte cultures submitted to different treatments, based on the analysis of cell viability, apoptosis 
induction detected by DNA fragmentation and observation of morphological alterations. 
2. Experimental Section 
2.1. Animals and Cell Isolation 
Forty Male Wistar rats  (45  days-old) were obtained from  the Animal House of the Veterinary 
School at the University of São Paulo (USP). The rats were maintained in boxes and fed with Nuvital
 
chow and water ad libitum until euthanasia in a CO2 chamber. 
Primary hepatocytes were obtained by the collagenase disaggregation technique [16]. The liver was 
excised,  cleaned  of  undesired  tissues,  cut  into  small  pieces  (1  mm
3)  and  washed  with  Phosphate 
Buffered Saline (PBS) to remove any red blood cells. Opti-MEM
 cell culture medium containing 
10% fetal bovine serum, 200 U/mL collagenase, 100 U/mL penicillin and 100 µg/mL streptomycin 
was then added to the tissue and the processed material was incubated at 37 °C for 4 h. Int. J. Mol. Sci. 2010, 11                       
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2.2. Cell Culture 
After  cell  disaggregation,  the  collagenase  was  removed  by  centrifugation.  The  cells  were 
resuspended in Opti-MEM
 medium containing 10% fetal bovine serum, their viability was checked 
by trypan blue exclusion and they were seeded at a high concentration (5,000-6,000 viable cells) onto 
24-well plates precoated with collagen. The plates were incubated at 37 °C in a 5% CO2 atmosphere. 
The cells were plated 24 h before initiating the experiment. They were detached with 0.25% trypsin 
and 0.03% versene prior to performing flow cytometry analysis and the observation of morphological 
alterations. 
2.3. Toxins 
The AFB1 used in the experiment was produced at Laboratory of Mycotoxins of the Biomedical 
Science Institute (USP), using toxigenic strains of Aspergillus flavus IMI 190. A small fragment of an 
A.  flavus  colony  was  inoculated  in  the  center  of  a  Petri  dish  with  coconut  agar.  Incubation  was 
conducted at 25 °C for 10 days, after which the cultures were assayed for aflatoxins, as described by 
Lin  and  Dianese  (1976)  [17].  The  coconut  agar  cultures  were  extracted  with  chloroform  (30  mL 
chloroform per 10 g of culture) by shaking for 30 min. The content was filtered through a Whatman #1 
filter paper and evaporated to dryness. Purification was achieved with hexane and partitioned with 
chloroform,  resulting  in  a  solution  of  96%  AFB1  and  4%  AFB2.  Quantification  was  achieved  by 
densitometry, as described by Oliveira et al. (2002) [18]. Given the toxicity of chloroform, the solution 
was placed in flasks, kept in a water bath at 60 °C until complete evaporation of the diluent and 
subsequently resuspended in dimethyl sulfoxide (DMSO). The concentrations of the standard were 
established according to the Manual of Official Methods of the Association of Official Analytical 
Chemistry [19].  
The  purified  FB1  (95%)  used  in  the  inoculation  of  the  cell  cultures  was  acquired  from  The 
Programme on Mycotoxins and Experimental Carcinogenesis (PROMEC Unit) of the South African 
Medical Research Council (MRC), South Africa, and was diluted in PBS. 
2.4. Treatments 
Primary  hepatocytes  were  incubated  in  culture  medium  containing  one  of  the  following 
concentrations:  T1,  9  nM  AFB1;  T2,  50  µM  FB1;  T3,  9  nM  AFB1  +  10  µM  FB1;  
T4, 9 nM AFB1 + 50 µM FB1; T5, 9 nM AFB1 + 100 µM FB1; and T6, 9 nM AFB1 + 250 µM FB1. 
The  control  group  was  incubated  with  0.25%  DMSO  alone.  All  experiments  were  performed  in 
triplicate and the cells were assayed after 1 to 4 h. 
2.5. Flow Cytometry Analysis 
Primary hepatocytes treated as described in Section 2.4; following trypsinization, 10
6 cells were 
resuspended in 5 mL D-PBS. Propidium iodide (10 ng/mL) was added and incubated for 10 min at  
37 °C, washed with PBS and resuspended in 0.8
 mL PBS. The treated cells were subjected to flow 
cytometric analysis (20000 events) using a FACScan (Becton Dickinson, San Jose, CA) by observing Int. J. Mol. Sci. 2010, 11                       
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the propidium iodide (564–606 nm). The distribution of cells and the percentage of dye-labeled cells 
were determined using the CellQuest software (Becton Dickinson). 
2.6. Detection of DNA Fragmentation by Agarose Gel Electrophoresis 
After removal of the culture medium, the cells were washed with PBS and 0.5 mL lysis buffer 
(100 mM hydroxymethyl aminomethane hydrochloride (Tris-HCl), pH 8.5, 5 mM ethylenediamine 
tetraacetic acid (EDTA), 0.2% sodium dodecyl sulfate (SDS), 200 mM NaCl, 100 µg/mL proteinase 
K) was added to each well. The plates were incubated overnight at 37 °C. After shaking for 30 min at 
room temperature, 0.5 mL of isopropanol was added to each well and the plates were again shaken 
until complete DNA precipitation. The DNA was transferred to a microtube and washed with 100 µL 
of  70%  ethanol.  Next,  the  ethanol  was  removed  and  the  microtubes  were  left  open  to  dry  for 
approximately 15 min. The DNA was resuspended in 25 µL TE buffer (10:1 Tris-HCL:EDTA) and 
incubated overnight at 55 °C to optimize dissolution.  
DNA  purity  was  checked  by  reading  at  an  optical  density  (OD)  of  260  and  280  nm  using  a 
spectrophotometer. The OD260/OD280 ratio was calculated and a value of 1.8 indicated pure DNA 
with  absence  of  contaminants,  such  as  proteins,  RNA  and  phenols.  DNA  quantification  was 
determined by diluting 10 µL of DNA and 990 µL of TE buffer and reading at OD 260 (Figure 1).  
Figure 1. Equation used to quantify the DNA. 
 
 
Samples of exactly 20 µg of DNA were submitted to 1.2% (w/v) agarose gel electrophoresis in 
0.5 × TAE  buffer  (Tris-Acetate-EDTA)  containing  0.5  µg/mL  ethidium  bromide  at  100  mV  for 
60 min. 
2.7. Observation of Morphological Alterations 
One and 4 h after toxin inoculation, 25 µL of the cell suspension (10
3 cells) was incubated with  
1  µL  of  the  following  solution:  1  part  acridine  orange  (100  µg/mL)/1  part  ethidium  bromide  
(100  µg/mL).  The  slides  were  observed  under  a  fluorescence  microscope,  almost  300  cells  were 
counted and the images were analyzed using Image Pro Plus software [20]. 
2.8. Statistical Analysis 
The results are reported as mean ± standard error of the mean. Differences between treatments over 
time were analyzed statistically by analysis of variance using a general linear model procedure and 
considering two factors: treatment (6 levels) and time (4 levels). A mean profile graph was constructed 
to  illustrate  the  results  [21].  A  significance  level  of  0.05  was  adopted.  Statistical  analysis  was 
performed using the SPSS (version 11.0) and SAS (version 8.01) programs. 
C = A/∑λ Int. J. Mol. Sci. 2010, 11                       
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3. Results and Discussion 
Analysis of the mean profile of the percentage of cell viability (Figure 2) revealed no differences 
between the different concentrations of FB1 and AFB1 (p = 0.8320). Cell viability decreased after one 
hour of incubation in all treatments compared to controls (p = 0.004). Statistically, a time-dependent 
effect (p = 0.0056) was observed; when comparing the viability data at two, three and four hours, no 
significant difference occurred between them in any of the treatments (p = 0.4274). In the present 
experiment,  although  a  decrease  in  viability  occurred  after  one  hour,  it  was  not  relevant  when 
considering that viability ranged from 82% to 84%. After four hours of exposure, the hepatocytes 
incubated with 9 nM AFB1 presented 83% of viable cells. Similar findings have been reported by Shen 
et al. (1996) (22), who demonstrated that more than 90% of cells treated with 10 nM AFB1 continued 
to be viable after four hours of incubation. 
Figure 2. Percentage of viable cells after one, two, three and four hours of incubation with: 
T1,  9  nM  AFB1;  T2,  50  µM  FB1;  T3,  9  nM  AFB1  +  10  µM  FB1;  
T4, 9 nM AFB1 + 50 µM FB1; T5, 9 nM AFB1 + 100 µM FB1; T6, 9 nM AFB1 + 250 µM 
FB1; and C, control. These data were obtained using general linear model procedures 
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A clear concentration-dependent increase in the cytotoxicity of bovine primary hepatocytes was 
observed by Kuilman et al. [23] using AFB1 doses and exposure times that were much higher than 
those used in the present study. The authors reported less than 40% viability for cells treated with 16 
µM AFB1 after 24 hours. When studying rat hepatocytes incubated with AFB1, Metcalfe and Neal [24] 
also reported signs of cytotoxicity that were proportional to the increase in the doses and exposure 
times studied. 
The effects observed for the isolated administration of FB1 are in agreement with those reported by 
several researchers. No evident alteration in cell viability irrespective of treatment and exposure time 
to FB1 has been reported in human fibroblasts [25], endothelial cells isolated from pig pulmonary 
artery (12) or in a human erythroleukemia cell line (K562) [26].  Int. J. Mol. Sci. 2010, 11                       
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In this experiment, the simultaneous administration of different concentrations of FB1 and AFB1 did 
not significantly alter cell viability compared to cells incubated with either toxin alone. Despite the 
toxin and concentration used, cell viability decreased after one hour of incubation, suggesting that the 
cellular viability may decrease in a time-dependent manner. 
In 1995, Wu  et  al.  [27]  demonstrated  that  FB1  was  not  cytotoxic  to  cardiomyocytes,  skeletal 
myocytes,  hepatocytes  or  macrophages,  but  its  effects  were  clearly  visible  in  splenocytes  and 
chondrocytes of primary chicken cell cultures. 
In contrast, some researchers have reported dose- and/or time-dependent effects of FB1 on some cell 
lines. While studying rabbit kidney epithelial cells (RK13), Rumora et al. [28] observed impaired cell 
viability  after  24  hours  of  exposure.  The  same  effects  were  reported  for  murine  macrophages 
(RAW264.7) [29], pig kidney epithelial cells (LLC-PK1) [30], the C6 cell line [31] and for human 
colon carcinoma cells (HT29) [32]. 
The effect of FB1 on the number of viable cells becomes clearer when taking into account the 
effects of this toxin on the cell cycle. In this respect, Bouhet et al. [33] analyzed the effects of FB1 on 
the cycle of intestinal (IPEC-1) and renal (LLC-PK1) epithelial cells and observed that the inhibition 
of  G0  to  G1  cell  cycle  progression  was  concomitant  with  the  effects  on  cell  proliferation.  The 
apoptosis induced by FB1 or cell cycle arrest was reported in CV-1 cells (African green monkey 
kidney fibroblasts) [34] and in rat hepatocytes [35], suggesting cell cycle-dependent cytotoxicity as a 
potential mechanism underlying the hepatocarcinogenicity of FB1. Other studies have indicated that 
FB1 may inhibit cell cycle progression in different phases; for example, cell cycle arrest in the G2/M 
phase  was  observed  in  rat  brain  glioma  cells  (C6)  [31]  and  in  esophageal  carcinoma  cells  
(WHCO3) [36]. 
Nucleosomal DNA fragmentation was observed in cells treated with FB1, AFB1 or a combination of 
these toxins. Fragmentation was more visible in cells treated with both toxins than with either toxin 
alone (line D of Figure 3). It was possible to determine which sample presented the most pronounced 
effect since the expression of the effect was determined using the same amount of DNA (20 µg) for 
each experiment. 
The classical biochemical marker of apoptosis is DNA laddering into oligosomes mediated by the 
endonucleolytic activity of caspase-3. Agarose gel electrophoresis of nuclear DNA extracted from 
apoptotic  cells  shows  a  typical  ladder  banding  pattern,  since  in  this  type  of  cell  death,  DNA 
fragmentation generally results in segments of approximately 180 to 200 bp and their multiples. In the 
case  of  necrosis,  DNA  fragmentation  is  random  and  the  electrophoretic  pattern  is  revealed  as  a  
screen [37]. 
The formation of a ladder pattern after incubation with FB1 has also been observed in African green 
monkey kidney cells (CV-1) [34] and in human neonatal keratinocytes (NHKc) [38]. These studies 
suggested that these alterations are related to the accumulation of sphinganine.  
According to Seefelder et al. [9], the characteristic formation of a DNA ladder and the condensation 
of chromatin in human immortalized proximal tubule cells (IHKE) is due to an increase in caspase-3 
activity.  Int. J. Mol. Sci. 2010, 11                       
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Figure  3.  DNA  ladder formation in primary  hepatocyte after three hours  of  exposure.  
A: Control (0.26% DMSO); B: 9 nM AFB1; C: 50µM FB1; D: 9 nM AFB1 + 10 µM FB1. 
A  B   C    D 
 
 
In contrast, DNA fragmentation was not observed in immortalized rabbit epithelial cells (RK13); 
however, the cells showed alterations in cell morphology compatible with the induction of apoptosis 
[28]. An absence of the nuclear effects of apoptosis seems to occur in certain cell lines, including 
WHCO3 esophageal cancer cells [36] and endothelial cells isolated from pig pulmonary artery, both 
incubated with FB1 [12]. 
Analysis  of  the  results  showed  that  the  concentrations  used  do  not  significantly  diminish  cell 
viability  during  the  treatment;  it  seems  that  FB1  did  not  delay  or  accelerate  the  decrease  in  cell 
viability. 
The data as presented indicate that 9 nM AFB1 caused cell death, including apoptosis in primary 
hepatocytes. Apoptosis induction also seems to be a concentration and time-dependent effect when 
FB1 and AFB1 are used in association. These data demonstrated that the enhanced apoptosis was due to 
the increased levels of FB1. 
Viable  cells  and  cells  in  early  and  late  apoptosis  can  be  differentiated  using  acridine 
orange/ethidium bromide. Apoptosis induction can be observed based on morphological alterations 
and  by  the  staining  properties  of  the  cells;  i.e.,  differential  uptake  of  the  dyes  is  an  important 
component in this differentiation. 
Acridine orange is a vital dye that stains both live and dead cells, ethidium bromide only stains cells 
that  have  lost  membrane  integrity,  while  live  and  heathy  cells  appear  uniformly  stained.  Early 
apoptotic cells stain green and contain bright dots in the nuclei. Late apoptotic cells also incorporate 
ethidium  bromide  and  show  condensed  and  often  fragmented  nuclei.  Necrotic  cells  also  stain  in 
orange, but present nuclear morphology resembling that of viable cells. 
Morphologically, the cells were classified as either live or apoptotic. Apoptotic cells are marked by 
cellular  shrinking,  condensation  and  margination  of  the  chromatin  and  ruffling  of  the  plasma 
membrane, called budding. Eventually the cell becomes divided into apoptotic bodies that consist of 
cell organelles and/or nuclear material surrounded by an intact plasma membrane. According to Van 
Cruchten  and  Van  den  Broeck,  hepatocyte  apoptosis  is  characterized  by  peculiar  morphological Int. J. Mol. Sci. 2010, 11                       
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features, including decreased cell volume, ruffled cell membranes, condensed chromatin beneath the 
nuclear envelope and, eventually, cell segregation with the formation of numerous vesicles containing 
intact organelles [39]. 
Characteristic morphological effects were observed in cells exposed to the toxins, thus confirming 
the results obtained by DNA fragmentation analysis.  
Although few cells showed evident apoptotic features after being treated with 9 nM of AFB1, at the 
highest concentration of toxin association (FB1 = 250 µM + AFB1 = 9nM), the signs included nuclear 
chromatin condensation and increased staining intensity and disintegration of the nuclear envelope and 
membrane-packaged DNA. At this point, the number of cells in late apoptosis was three-fold higher 
than the previous concentration (FB1 = 100 µM + AFB1 = 9nM), as shown in Figure 4.  
Figure 4. Photomicrography of the primary rat hepatocytes submitted to the following 
treatments: A: Control (0.26% DMSO); B: 9nM AFB1 + 100µM FB1; C: 9nM AFB1 + 
250µM FB1; D: 9nM AFB1, stained with acridine orange and ethidium bromide (original 
magnification x600). Arrows indicate apoptotic nuclei. 
 
 
 
 
At the other concentrations of FB1 alone and in association with AFB1, cellular dehydration was 
evident, with modifications in shape and size, as well as chromatin condensation and hyperchromasia.  
The data suggested that the promotion of an apoptotic effect by FB1 increased in a concentration 
and time-dependent manner and this effect was further highlighted when this toxin was administered in 
association with AFB1. In vivo and in vitro experiments suggest that FB1 behaves in a manner similar 
to most cancer promoters by inducing differential growth in initiated cells [40].  
A 
C  D 
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Others authors reported similar results when conducting in vitro studies, verifying that coexposure 
to  fumonisins  and  AFB1  produced  greater  liver  toxicity  compared  to  their  administration  alone, 
inducing apoptosis and mitotic hepatocytes. Inversion of the typical Sa:So ratio occurred in rats [41]; 
therefore, the mixture of fumonisins and AFB1 induced toxic responses that could not be considered 
the sum of the effects caused individually by these mycotoxins [42]. 
In the present study, the morphological alterations observed, the ladder-like electrophoretic pattern 
and chromatin condensation accompanied by nuclear fragmentation, indicate that the effects on the 
cells was caused by chromatin breakage, thus characterizing cell death by apoptosis. These results are 
in agreement with those obtained studying nonimmortalized human fibroblasts exposed to FB1, in 
which  the DNA  damage  observed was  dose-dependent  [25].  Modifications corresponding to early 
apoptosis have also been demonstrated by Minervini et al. [26] in K563 human erythroleukemia cells 
submitted to treatment with FB1. 
The interaction between different natural occurring toxins, such as aflatoxins and fumonisins are 
very complex and the present study indicates that more emphasis should placed on these interactions to 
aid in the elucidation of the toxicological and carcinogenic effects of these toxins. 
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